Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 203,962Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 27Actelion Pharmaceuticals Ltd

02 6Alembic Pharmaceuticals Limited

03 8Centocor

04 20Johnson & Johnson Innovative Medicine

05 8MSN Laboratories

06 8Pluviaendo

07 8Vgyaan Pharmaceuticals

08 8Zydus Lifesciences

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.2MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.4MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.6MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.8MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 1.2MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 1.4MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 1.6MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : 1.8MG/VIAL

Packaging :

Approval Date : 2021-07-29

Application Number : 214275

Regulatory Info : RX

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 200MCG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 400MCG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 600MCG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 800MCG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 1000MCG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 1200MCG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 1400MCG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 1600MCG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 0.2MG

Packaging :

Approval Date : 2022-12-21

Application Number : 214302

Regulatory Info : DISCN

Registration Country : USA

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 0.4MG

Packaging :

Approval Date : 2022-12-21

Application Number : 214302

Regulatory Info : DISCN

Registration Country : USA

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 0.6MG

Packaging :

Approval Date : 2022-12-21

Application Number : 214302

Regulatory Info : DISCN

Registration Country : USA

blank